Get the Daily Brief
Latest Biotech News
Innovative Antibody–Bottlebrush Prodrugs Enhance Targeted Cancer Therapy
Scientists at MIT have engineered antibody–bottlebrush conjugates that expand antibody-drug conjugate (ADC) payload flexibility by enabling higher drug-to-antibody ratios and inclusion of lower...
Immune System Aging Markers Identified in Early Rheumatoid Arthritis
A University of Birmingham study discovered premature immune aging signatures present during the earliest stages of rheumatoid arthritis (RA), prior to clinical diagnosis. This pivotal finding...
Novartis Bets $1.4B on Tourmaline’s Heart Drug to Challenge Cardio Giants
Novartis announced a $1.4 billion acquisition of Tourmaline Bio, securing rights to pacibekitug, a promising Phase 3-ready antibody targeting atherosclerotic cardiovascular disease. The drug aims...
Rapport’s Seizure Drug RAP-219 Surges With Strong Phase II Data
Rapport Therapeutics released compelling Phase II results for RAP-219, a TARPγ8-specific AMPAR negative allosteric modulator aimed at treating drug-resistant focal onset seizures. The trial showed...
Distinguished Biotech Veteran Harvey Berger Named Arena BioWorks CEO
Arena BioWorks, launched in 2024 with $500 million funding from high-profile billionaires, has appointed biotech veteran Harvey Berger as its new CEO. Berger reunites with co-founder Stuart...
Breakthrough in Glioblastoma: Extrachromosomal DNA Drives Tumor Evolution
An international research consortium has shed light on the role of circular extrachromosomal DNA (ecDNA) elements in the progression and treatment resistance of glioblastoma, the deadliest brain...
Lilly Opens AI Drug Discovery Platform to Biotech Startups
Eli Lilly has launched TuneLab, an AI-powered platform granting biotech firms access to Lilly’s trained drug discovery models in exchange for contributing their data to improve the system....
New Alzheimer’s Vaccine ALZ-101 Moves to Phase II After FDA Approval
Swedish biopharmaceutical company Alzinova secured FDA approval to initiate a Phase II clinical trial for ALZ-101, a vaccine candidate targeting toxic amyloid-beta oligomers implicated in...
Biotech Startup RedC Aims to Mass-Produce Lab-Grown Universal Blood
RedC Biotech, a budding company founded by Dr. Ari Gargir, is developing technology to cultivate red blood cells from stem cells at scale. The approach intends to create universal donor blood...
New AI Model Predicts Long-Term Stability of Biotherapeutic CHO Cell Lines
Researchers at MIT have developed and publicly released an AI-driven model that forecasts the long-term stability of Chinese Hamster Ovary (CHO) cell lines used extensively in biotherapeutic...
Phase II Data Elevate Dianthus Therapeutics in Generalized Myasthenia Gravis
Dianthus Therapeutics announced positive Phase II outcomes for its selective complement inhibitor in patients with generalized myasthenia gravis (gMG). The results indicate meeting multiple...
Mid-Stage Success with Antibody–Bottlebrush Prodrugs Enhances Cancer Therapy Options
A series of groundbreaking publications in Nature Biotechnology introduce antibody–bottlebrush prodrugs as next-generation targeted cancer therapies. These constructs allow higher drug-to-antibody...
Novartis Completes $1.4B Tourmaline Acquisition for Cardiovascular Drug
Novartis has finalized the $1.4 billion acquisition of Tourmaline Bio, securing pacibekitug, a promising anti-IL-6 monoclonal antibody targeting atherosclerotic cardiovascular disease (ASCVD)....
Rapport Therapeutics Advances with High-Efficacy Seizure Drug in Phase II
Rapport Therapeutics reported exceptional Phase II data for RAP-219, a TARPγ8-specific AMPAR modulator aimed at drug-resistant focal onset seizures. The open-label study showed a median 78%...
Eli Lilly Opens AI Platform TuneLab to Biotech Startups
Eli Lilly launched 'TuneLab,' an AI platform granting selected biotech companies access to pre-trained drug discovery models developed from Lilly’s extensive R&D data. In exchange for access,...
Breakthrough AI Model Predicts Long-Term Cell Line Stability for Biologics
Scientists at MIT unveiled the first publicly available AI model predicting long-term stability of Chinese Hamster Ovary (CHO) cell lines over 72 passages, aligning with FDA stability metrics....
Antibody–Bottlebrush Prodrugs Enhance Targeted Cancer Therapies
Innovative research published in Nature Biotechnology describes antibody–bottlebrush prodrug conjugates that expand payload diversity beyond conventional antibody–drug conjugates (ADCs). These...
New Clinical Advances in Small Cell and Non-Small Cell Lung Cancer
At the 2025 World Conference on Lung Cancer, multiple studies showcased advances in lung cancer treatment. BioNTech and Bristol Myers Squibb’s bispecific PD-L1/VEGF inhibitor pumitamig...
RedC Biotech Develops Lab-Grown Universal Blood Supply
Israeli startup RedC Biotech is pioneering large-scale production of universal-type red blood cells derived from stem cells. Utilizing expansive bioreactors, the technology aims to overcome global...
Novel Single-Cell Sequencing Trial Targets Myelodysplastic Syndrome Diagnosis
Researchers at the Weizmann Institute have initiated the PERIBLOOD clinical trial to evaluate single-cell sequencing as a minimally invasive diagnostic alternative to bone marrow biopsies for...